当前位置:
X-MOL 学术
›
Curr. Opin. Ophthalmol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Description and management of retinopathy of prematurity reactivation after intravitreal antivascular endothelial growth factor therapy.
Current Opinion in Ophthalmology ( IF 3.7 ) Pub Date : 2021-8-17 , DOI: 10.1097/icu.0000000000000786 Nita G Valikodath 1 , Michael F Chiang 2 , R V Paul Chan 1
Current Opinion in Ophthalmology ( IF 3.7 ) Pub Date : 2021-8-17 , DOI: 10.1097/icu.0000000000000786 Nita G Valikodath 1 , Michael F Chiang 2 , R V Paul Chan 1
Affiliation
To review the literature regarding reactivation of retinopathy of prematurity (ROP) after treatment with antivascular endothelial growth factor (anti-VEGF) agents.
中文翻译:
玻璃体内抗血管内皮生长因子治疗后早产儿再激活视网膜病变的描述和治疗。
综述有关抗血管内皮生长因子(抗 VEGF)药物治疗后早产儿视网膜病变(ROP)再激活的文献。
更新日期:2021-08-17
中文翻译:
玻璃体内抗血管内皮生长因子治疗后早产儿再激活视网膜病变的描述和治疗。
综述有关抗血管内皮生长因子(抗 VEGF)药物治疗后早产儿视网膜病变(ROP)再激活的文献。